Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CoreValve Advance-II Study: Best Practices Investigation of Patients Implanted With the Medtronic CoreValve Bioprosthesis.

NCT01624870 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.

NCT NCT01624870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01624870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CoreValve Advance-II Study: Best Practices Investigation of Patients Implanted With the Medtronic CoreValve Bioprosthesis.
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
March 31, 2014
Enrollment
200 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, valvular heart disease